Skyline Medical to Demonstrate Revolutionary Technology at Association of periOperative Registered Nurses Conference
Influential AORN members will see firsthand benefits of the safer, environmentally sound STREAMWAY® Fluid Waste Management System
MINNEAPOLIS, March 18, 2014 /PRNewswire/ -- Skyline Medical (OTCQB: SKLN) will exhibit its revolutionary, FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal at the Association of periOperative Registered Nurses (AORN) Surgical Conference & Expo in late March in Chicago.
Skyline Medical will demonstrate the STREAMWAY System from March 30 - April 2, 2014, at McCormick Place in Chicago, at booth #1155.
"Nurses are on the front lines of waste fluid management. They're the ones most at risk of exposure from antiquated fluid disposal methods, such as suction canisters and mobile cart systems, which require handling and transporting potentially infectious fluid," said Josh Kornberg, CEO of Skyline Medical. "That's why our safer, fully automated STREAMWAY System has resonated with so many nurses - and why they're often influential in persuading their facility administrators to install our state-of-the-art fluid disposal technology."
Additionally, the STREAMWAY System supports AORN's position on Environmental Responsibility, which states the perioperative registered nurse should serve as a steward of the environment by being knowledgeable about environmental issues affecting perioperative practice, and by actively promoting and participating in resource conservation, including waste and hazardous agent management.
The STREAMWAY System is a one-piece, wall-mounted unit that connects directly to a facility's plumbing, thereby eliminating the cost and environmental waste of canisters. By using the STREAMWAY System, healthcare facilities help eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United States.
"After seeing our breakthrough technology for themselves, nurses better appreciate the many positive impacts the STREAMWAY System can have on their practices - in terms of safety, budget, efficiency and environmental stewardship," Kornberg said.
About Skyline Medical Inc.
Skyline Medical Inc. produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods - which require hand carrying and emptying filled-fluid canisters - present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers, 2) improve compliance with Occupational State and Health Association (OSHA) and other regulatory agency safety guidelines, 3) improve efficiency in the operating room, and radiology and endoscopy departments - leading to greater profitability, and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United States. For additional information, please visit: www.skylinemedical.com.
Forward-looking Statements
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, inability to raise sufficient additional capital to operate our business; approximately $3.2 million in debts, liabilities and cash obligations that become due over the next twelve months; unexpected costs and operating deficits, and lower than expected sales and revenues, if any; adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; and inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the Company's most recent Annual Report on Form 10-K, as amended, and subsequent 8-K and other filings at www.sec.gov.
Skyline Investor Relations Contacts:
Phil Carlson / Elizabeth Barker
KCSA Strategic Communications
212-896-1233 / 212-896-1203
[email protected]
Public Relations Contact:
David Dauwalter
Skyline Medical Inc
651-389-4800
[email protected]
SOURCE Skyline Medical
Share this article